Dr Olayinka O.Ogunleye

MBBS(IB), MSc (Epid&Med Stat), FMCP (Nig)

olayinka.ogunleye@lasucom.edu.ng

Academic Background, Trainings, Skills, Positions, Teaching, Achievements (in Summary).

Dr Olayinka Ogunleye is a Consultant Physician and Clinical Pharmacologist with extensive global networks and collaborations. He currently Chairs the Global Health Pharmacology and Therapeutics Sub-committee (formerly Sub-committee for Clinical Pharmacology in Developing Countries) of The International Union of Basic and Clinical Pharmacology (IUPHAR)- the global umbrella body of all pharmacological societies and serves as the President of The Nigerian Society for Clinical Pharmacology and Therapeutics (NSCPT). He is also a member of The International Advisory Group of The British Pharmacological Society (BPS) and a Co-founder of The Medicines Utilization Research in Africa (MURIA) Group; a cross national group of experts promoting the rational use of medicines in Africa. ` He is a World Health Organisation trained Clinical Monitor with expertise in Experimental Therapeutics and Drug Utilization Research. He is a graduate of Medicine and Surgery (M.B,B.S) from The University of Ibadan and The University College Hospital, Ibadan, Nigeria with Postgraduate Trainings in Internal Medicine, Clinical Pharmacology and Therapeutics, Cardiology, Epidemiology and Medical Statistics. He is a Fellow of the National Postgraduate Medical College of Nigeria in Internal Medicine with sub-specialization in Clinical Pharmacology and Therapeutics. His passion lies in providing cost effective preventive and therapeutic solutions to the global burden of communicable and non-communicable diseases with the highest ethical and scientific standards. He is a member of The International Editorial Board of The British Journal of Clinical Pharmacology (BJCP) as well as an Associate Editor to Frontiers in Pharmacology (Pharmaceutical Medicine and Outcome Research).

Research Interests/Specialisations

1. Pharmacoepidemiology and Drug Utilization Studies (DUR) and Pharmacoeconomics 2. Antimirobial Resistances (AMR) 3. Pharmacotherapy of Hypertension and Diabetes Mellitus 4. Clinical Trials and Experimental Therapeutics 5. Medical and Pharmacology Education. 6. General Internal Medicine 7. Vaccinology and Drug Development.

Publications

1. Olayinka O. Ogunleye, Modupe R. Oyawole, Patricia T. Odunuga, Folasade Kalejaye, Adesola F. Yinka-Ogunleye, Adesola Olalekan, Sunday O. Ogundele, Bernard E. Ebruke, Atinuke Kalada Richard, Bene D Anand Paramadhas, Amanj Kurdi, Jacqueline Sneddon, Andrew Seaton & Brian Godman (2021)
A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications, Expert Review of Anti-infective Therapy,
DOI: 10.1080/14787210.2021.1941870

A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications, Expert Review of Anti-infective Therapy, DOI: 10.1080/14787210.2021.1941870

2. Brian Godman , Abiodum Egwuenu, Mainul Haque, Oliver Ombeva Malande, Natalie Schellack, Santosh Kumar, Zikria Saleem, Jacqueline Sneddon, Iris Hoxha, Salequl Islam, Julius Mwita, Renata Cristina Rezende Macedo do Nascimento, Isabella Piassi Dias Godói, Loveline Lum Niba, Adefolarin A Amu, Joseph Acolatse, Robert Incoom, Israel Abebrese Sefah, Sylvia Opanga, Amanj Kurdi, Ibrahim Chikowe, Felix Khuluza, Dan Kibuule, Olayinka O Ogunleye, Adesola Olalekan, Vanda Markovic-Pekovic, Johanna C Meyer, Abubakr Alfadl, Thuy Nguyen Thi Phuong, Aubrey C Kalungia, Stephen Campbell, Alice Pisana, Janney Wale, R Andrew Seaton.
Ongoing strategies to improve antimicrobial utilization with a special focus on developing countries. Life 2021, 11, 528.https://doi.org/10.3390/life11060528

Ongoing strategies to improve antimicrobial utilization with a special focus on developing countries. Life 2021, 11, 528

.https://doi.org/10.3390/life11060528

3. Ogunleye OO, Basu D, Mueller D,Sneddon J, Seaton RA,Yinka-Ogunleye AF, Wamboga J,Miljkovic´ N,Mwita JC, Rwegerera GM,Massele A, PatrickO, Niba LL, Nsaikila M,Rashed WM, Hussein MA, Hegazy R,Amu AA, Boahen-Boaten BB,Matsebula Z, Gwebu P, Chirigo B,Mkhabela N, Dlamini T, Sithole S,Malaza S, Dlamini S, Afriyie D, Asare GA,Amponsah SK, Sefah I, Oluka M,Guantai AN, Opanga SA, Sarele TV,Mafisa RK, Chikowe I, Khuluza F,Kibuule D, Kalemeera F, Mubita M,Fadare J, Sibomana L, Ramokgopa GM,Whyte C, Maimela T, Hugo J, Meyer JC,Schellack N, Rampamba EM, Visser A,Alfadl A, Malik EM, Malande OO,Kalungia AC, Mwila C, Zaranyika T,Chaibva BV, Olaru ID, Masuka N, Wale J,Hwenda L, Kamoga R, Hill R, Barbui C,Bochenek T, Kurdi A, Campbell S,Martin AP,Phuong TNT, Thanh BN, GodmanB(2020)
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front. Pharmacol. 11:1205.
doi: 10.3389/fphar.2020.01205

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front. Pharmacol. 11:1205.

doi: 10.3389/fphar.2020.01205

4. Mwita JC, Ogunleye OO, Olalekan A,
et al. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications. Int J Gen Med. 2021;14:515-530. Published 2021 Feb 18.
doi:10.2147/IJGM.S253216

Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications. Int J Gen Med. 2021;14:515-530. Published 2021 Feb 18. doi:10.2147/IJGM.S253216

5. Brian Godman, Joseph Fadare, Dan Kibuule, Lyna Irawati, Mwangana Mubita, Olayinka Ogunleye, Margaret Oluka, Bene D Anand Paramadhas, Juliana de Oliveira Costa, Lívia Lovato Pires de Lemos, Augusto Afonso Guerra Júnior, Alian A Alrasheedy, Mohamed Azmi Hassali, Fahad Saleem, Thu Huong, Ilse Truter. (2016) Initiatives across countries to reduce antibiotic utilization and resistance patterns; impact and implications. 2017
A chapter in Drug Resistance in Bacteria, Fungi, Malaria and Cancer, pg 539-576. by Springer.
http://www.springer.com/us/book/9783319486826

A chapter in Drug Resistance in Bacteria, Fungi, Malaria and Cancer, pg 539-576. by Springer. http://www.springer.com/us/book/9783319486826

6. Sefah IA, Ogunleye OO, Essah DO, Opanga SA, Butt N, Wamaitha A, Guantai AN, Chikowe I, Khuluza F, Kibuule D, Nambahu L, Abubakar AR, Sani IH, Saleem Z, Kalungia AC, Thi Phuong TN, Haque M, Islam S, Kumar S, Sneddon J, Wamboga J, Wale J, Miljkovi ´c N, Kurdi A, Martin AP and Godman B (2020)
Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Front. Pharmacol. 11:588106.
doi: 10.3389/fphar.2020.588106

Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Front. Pharmacol. 11:588106. doi: 10.3389/fphar.2020.588106

7. Olayinka O. Ogunleye, Joseph O. Fadare, Jaran Eriksen, Omo Oaiya, Amos Massele, Ilse Truter, Simon J.E. Taylor, Brian Godman, Lars L. Gustafsson. (2019)
Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health, Expert Review of Clinical Pharmacology, 12:5, 481-489,
DOI:10.1080/17512433.2019.1605903

Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health, Expert Review of Clinical Pharmacology, 12:5, 481-489, DOI:10.1080/17512433.2019.1605903

8. Joseph O.Fadare, Olayinka Ogunleye, Garba Iliyasu, Adekunle Adeoti, Natalie Schellack, Deirdre Engler, Amos Massele, Brian Godman (2018)
Status of antimicrobial stewardship programs in Nigerian tertiary healthcare facilities; findings and implications. Global Antimicrobial Resistance,
https://doi.org/10.1016/j.jgar.2018.11.025

Status of antimicrobial stewardship programs in Nigerian tertiary healthcare facilities; findings and implications. Global Antimicrobial Resistance, https://doi.org/10.1016/j.jgar.2018.11.025

9. Olayinka O. Ogunleye, Joseph O. Fadare, Adesola F. YinkaOgunleye, Bene D. Anand Paramadhas, Brian Godman (2018):
Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital, Hospital Practice, DOI: 10.1080/21548331.2018.1475997 [Epub ahead of print]
https://doi.org/10.1080/21548331.2018.1475997

Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital, Hospital Practice, DOI: 10.1080/21548331.2018.1475997 [Epub ahead of print] https://doi.org/10.1080/21548331.2018.1475997

10. Olayinka O. Ogunleye, Ibrahim A. Oreagba, Catherine Falade, Ambrose Isah, Okezie Enwere, Sunday Olayemi, Sunday O.Ogundele et al.(2016).
Medication Errors Among Health Professionals in Nigeria: A National Survey. IJRSM; 28(2):77-91.
Doi: 10.3233/JRS-160721

Medication Errors Among Health Professionals in Nigeria: A National Survey. IJRSM; 28(2):77-91.

Doi: 10.3233/JRS-160721

Dr Olayinka O.Ogunleye